Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stem Cell Infusion”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00376480
What this trial is testing

Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Dana-Farber Cancer Institute 19
Testing effectiveness (Phase 2)UnknownNCT04346368
What this trial is testing

Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Guangzhou Institute of Respiratory Disease 20
Testing effectiveness (Phase 2)UnknownNCT03943940
What this trial is testing

BM-MNCs and UC-MSCs Infusion for Type 2 Diabetes Mellitus Patients

Who this might be right for
Type 2 Diabetes Mellitus
Van Hanh General Hospital 60
Testing effectiveness (Phase 2)UnknownNCT01954147
What this trial is testing

Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Diabetes Care Center of Nanjing Military Command 100
Not applicableNo Longer AvailableNCT04657458
What this trial is testing

Expanded Access for Use of bmMSC-Derived Extracellular Vesicles in Patients With COVID-19 Associated ARDS

Who this might be right for
Covid19ARDSHypoxia+1 more
Direct Biologics, LLC
Testing effectiveness (Phase 2)UnknownNCT01513109
What this trial is testing

Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia

Who this might be right for
Acute Myelogenous LeukemiaMyeloid Leukemia in RemissionEffects of Immunotherapy
Jules Bordet Institute 20
Testing effectiveness (Phase 2)Study completedNCT00371371
What this trial is testing

Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI)

Who this might be right for
Peripheral Vascular DiseasesArterial Occlusive DiseasesLeg Ulcer+2 more
UMC Utrecht 160
Early research (Phase 1)Study completedNCT00004892
What this trial is testing

O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00794261
What this trial is testing

Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma

Who this might be right for
LymphomaMyeloma
Centre Leon Berard 150
Testing effectiveness (Phase 2)Ended earlyNCT04166929
What this trial is testing

Haploidentical Stem Cell Transplant With or Without NK Cell Infusion in AML and MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasia
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 6
Testing effectiveness (Phase 2)Study completedNCT02472691
What this trial is testing

Azacitidine, Lenalidomide and DLI as Salvage Therapy for MDS, CMML and sAML Relapsing After Allo-HSCT

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Heinrich-Heine University, Duesseldorf 50
Not applicableActive Not RecruitingNCT04437771
What this trial is testing

Long-Term Follow-up of Subjects With Fanconi Anaemia Subtype A Treated With ex Vivo Gene Therapy

Who this might be right for
Fanconi Anemia Complementation Group AFanconi Anemia
Rocket Pharmaceuticals Inc. 9
Testing effectiveness (Phase 2)Ended earlyNCT00289822
What this trial is testing

Cell Therapy for Coronary Heart Disease

Who this might be right for
Coronary Artery Disease
Johann Wolfgang Goethe University Hospital 75
Large-scale testing (Phase 3)Looking for participantsNCT07366801
What this trial is testing

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia, RelapsedAcute Lymphoblastic Leukemia, High RiskAcute Myeloid Leukemia, High Risk+1 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Not applicableNo Longer AvailableNCT02158767
What this trial is testing

Access Protocol. Infusion of CD34+ Enriched, T Cell Depleted Hematopoietic Stem Cell Grafts.

Who this might be right for
Hematopoietic/Lymphoid Cancer
Leland Metheny
Large-scale testing (Phase 3)Looking for participantsNCT05686538
What this trial is testing

Innate Donor Effector Allogeneic Lymphocyte Infusion After Stem Cell Transplantation: the IDEAL Trial

Who this might be right for
AML/MDS
Rigshospitalet, Denmark 80
Testing effectiveness (Phase 2)Study completedNCT04992832
What this trial is testing

Multi-intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Heart Failure With Reduced Ejection Fraction（PRIME-HFrEF Study）

Who this might be right for
Heart Failure, Systolic
Shanghai East Hospital 40
Early research (Phase 1)UnknownNCT00935597
What this trial is testing

Host Dendritic Cells in Allograft Patients

Who this might be right for
Relapsed Non-Hodgkin's LymphomaHodgkin's DiseaseMultiple Myeloma+1 more
Icahn School of Medicine at Mount Sinai 25
Large-scale testing (Phase 3)Active Not RecruitingNCT06294678
What this trial is testing

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies

Who this might be right for
Acute Graft-versus-host Disease
Anhui Provincial Hospital 198
Early research (Phase 1)Active Not RecruitingNCT04013685
What this trial is testing

Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMyelodysplastic Syndromes+3 more
Orca Biosystems, Inc. 155
Next Page
64